Palisade Bio appoints Emil Chuang to board; Fischbein resigns

PALISADE BIO, INC.

Margery Fischbein resigned from board effective July 2, 2025; no disagreement with company.
Board accelerated vesting of Fischbein's 3,100 outstanding stock options to fully vested.
Emil Chuang, MB BS FRACP, appointed to board effective July 7, 2025; also joins audit, compensation, governance committees.
Chuang is a pediatric gastroenterologist with nearly 25 yrs experience, contributed to two NDA/sBLA approvals.
Chuang granted non-statutory stock option to purchase 8,000 shares at closing price on grant date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.